GPNX
NOTIFICATION PROCESSED BY IB
11/12/2023
Back to search
Official data from USPTO
APHEXDA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
11/12/2023
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
08/17/2022
Registration date
09/26/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2023
Last transaction
09/26/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IL
Examiner
BIBB, SCOTT
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BioLineRx Ltd.
Representatives
Adv. Lihi Katzenelson
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicine for mobilization of stem cells
Publications
History of USPTO decisions and trademark events.
16 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/26/2023
FIMP
FINAL DISPOSITION PROCESSED
10/26/2023
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
10/26/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/19/2023
GPNX
NOTIFICATION PROCESSED BY IB
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/21/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/21/2023
NPUB
NOTICE OF PUBLICATION
06/21/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/07/2023
DOCK
ASSIGNED TO EXAMINER
06/05/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/29/2022
Continuous trademark protection
Get notified about every new filing that threatens APHEXDA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.